Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GoodRx HoldingsGDRX +0.57%70 EV-to-OCF is 7.18 as of Aug. 31, 2026, which is 56% below its 10-year median of 16.31. GuruFocus rates GDRX with a GF Score™ of 70/100 and a GF Value™ of $5.29 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 55.91% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, GoodRx Holdings's Enterprise Value is $1,447.1 Mil.
GoodRx Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $201.6 Mil. Therefore, GoodRx Holdings's EV-to-OCF for today is 7.18.
The historical rank and industry rank for GoodRx Holdings's EV-to-OCF or its related term are showing as below:
GDRX'
s EV-to-OCF Range Over the Past 10 Years
Min: 5.5 Med: 16.31 Max: 176.27
Current: 7.18
During the past 8 years, the highest EV-to-OCF of GoodRx Holdings was 176.27. The lowest was 5.50. And the median was 16.31.
GDRX's EV-to-OCF is ranked better than 55.91% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 9.12
vs GDRX: 7.18
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GoodRx Holdings's PE Ratio (TTM) for today is calculated as:
GoodRx Holdings's share price for today is $3.53.
GoodRx Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GoodRx Holdings EV-to-OCF Related Terms
GoodRx Holdings EV-to-OCF Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's EV-to-OCF falls into.
GoodRx Holdings's current Enterprise Value is $1,447.1 Mil.
GoodRx Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $201.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a EV-to-OCF of 7.18 as of Aug. 31, 2026. This is 56% below median its historical median of 16.31. Over the past decade, GoodRx Holdings' EV-to-OCF has ranged from 5.50 to 176.27. According to the industry distribution chart, GoodRx Holdings ranks #302 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 44.1%.
Is GoodRx Holdings' EV-to-OCF too high?
GoodRx Holdings' current EV-to-OCF of 7.18 is 56% below median its 10-year median of 16.31. Over the past 10 years, this metric has ranged from a low of 5.50 to a high of 176.27. The Healthcare Providers & Services industry median EV-to-OCF is 9.12. GoodRx Holdings' value of 7.18 is 21.3% below this industry median. Based on the distribution chart, GoodRx Holdings ranks #302 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GoodRx Holdings has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' EV-to-OCF compare to TDOC and CERT?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #302 out of 685 companies for EV-to-OCF. This puts GoodRx Holdings in the upper half of its industry. The industry median EV-to-OCF is 9.12. GoodRx Holdings' value of 7.18 is 21.3% below this benchmark. Historically, GoodRx Holdings' own EV-to-OCF has ranged from 5.50 to 176.27 over the past decade. While the company's 10-year median is 16.31 vs. the industry median of 9.12, GoodRx Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 9.12, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current EV-to-OCF of 7.18 is 21.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 9.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current EV-to-OCF is 7.18, which is 56% below median its own 10-year median of 16.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.29, compared to a current price of $3.53 — trading 33.3% below its estimated fair value. The current EV-to-OCF is 7.18, which is 56% below median its 10-year median of 16.31 and 21.3% below the Healthcare Providers & Services industry median of 9.12. GoodRx Holdings' overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current EV-to-OCF is 7.18 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $3.53 is trading 33.3% below its estimated GF Value™ of $5.29.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
EV-to-OCF: 7.18 (56% below median its 10-year median of 16.31)
GF Value™: $5.29 vs. price of $3.53 (33.3% below fair value)
Industry Position: 21.3% below the Healthcare Providers & Services median (#302 of 685)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
70GF Score
Get the complete analysis for GDRX
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
